Validation of the Russian version of the pelvic pain and urgency/frequency patient symptom scale (C.L. Parsons, 2000) for patients with chronic recurrent uncomplicated cystitis

Abstract

BACKGROUND: Questionnaires allow to objectify and quantify the disease severity, especially at the patient’s initial visit, its impact on the patients’ quality of life, as well as the dynamics of symptoms during treatment.

AIM: To validate the Russian version of the Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF scale; C.L. Parsons, 2000) for patients with chronic recurrent uncomplicated cystitis.

MATERIALS AND METHODS: The Russian version of the PUF Scale was suggested to two respondent groups aged 19 to 53 years: relatively healthy volunteers, 15 women who did not complains of urinary disorders or pain/discomfort in the bladder, and 14 patients with verified diagnosis of chronic recurrent uncomplicated cystitis.

RESULTS: The resulting data demonstrate the validity of the proposed Russian version of the PUF Scale. Statistically significant differences were noted in the answers to most of the questionnaire issues between two respondent groups: conditionally healthy volunteers and patients with chronic recurrent uncomplicated cystitis. A high level of internal consistency of the questionnaire was found. Cronbach’s alpha coefficient in the main group was 0.888, in the control group — 0.819.

CONCLUSIONS: The study findings proved that the Russian version of the Pelvic Pain and Urgency/Frequency Patient Symptom Scale (C.L. Parsons, 2000) is a valid tool for subjective assessment of the severity of chronic recurrent uncomplicated cystitis symptoms.

Keywords

lower urinary tract infection / cystitis / Pelvic Pain and Urgency/Frequency Patient Symptom Scale / PUF Scale / dysuria

References

[1] Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: A review. Sultan Qaboos Univ Med J. 2013;13(3):359–367. doi: 10.12816/0003256

[2] Al-Badr A., Al-Shaikh G. Recurrent urinary tract infections management in women: A review // Sultan Qaboos Univ Med J. 2013. Vol. 13, N 3. P. 359–367. doi: 10.12816/0003256

[3] Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: A review. Sultan Qaboos Univ Med J. 2013;13(3):359–367. doi: 10.12816/0003256

[4] Kulchavenya EV, Neimark AI, Kondratieva YuS. Diseases of the urinary bladder. Saarbrücken: Palmarium Academium Publishing; 2013. 140 p. (In Russ.)

[5] Кульчавеня Е.В., Неймарк А.И., Кондратьева Ю.С. Заболевания мочевого пузыря. Саарбрюккен: Palmarium Academium Publishing, 2013. 140 с.

[6] Kulchavenya EV, Neimark AI, Kondratieva YuS. Diseases of the urinary bladder. Saarbrücken: Palmarium Academium Publishing; 2013. 140 p. (In Russ.)

[7] Mancuso G, Trinchera M, Midiri A, et al. Novel antimicrobial approaches to combat bacterial biofilms associated with urinary tract infections. Antibiotics (Basel). 2024;13(2):154. doi: 10.3390/antibiotics13020154

[8] Mancuso G., Trinchera M., Midiri A., et al. Novel antimicrobial approaches to combat bacterial biofilms associated with urinary tract infections // Antibiotics (Basel). 2024. Vol. 13, N 2. ID 154. doi: 10.3390/antibiotics13020154

[9] Mancuso G, Trinchera M, Midiri A, et al. Novel antimicrobial approaches to combat bacterial biofilms associated with urinary tract infections. Antibiotics (Basel). 2024;13(2):154. doi: 10.3390/antibiotics13020154

[10] Rafalsky VV, Moiseeva EM. Epidemiology of uncomplicated outpatient urinary tract infections in the Russian Federation. Urology Herald. 2018;6(2):30–37. EDN: XSQNHN doi: 10.21886/2308-6424-2018-6-2-30-37

[11] Рафальский В.В., Моисеева Е.М. Эпидемиология неосложненных внебольничных инфекций мочевыводящих путей в Российской Федерации // Вестник урологии. 2018. Т. 6, № 2. С. 30–37. EDN: XSQNHN doi: 10.21886/2308-6424-2018-6-2-30-37

[12] Rafalsky VV, Moiseeva EM. Epidemiology of uncomplicated outpatient urinary tract infections in the Russian Federation. Urology Herald. 2018;6(2):30–37. EDN: XSQNHN doi: 10.21886/2308-6424-2018-6-2-30-37

[13] Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259–268. doi: 10.1016/s0924-8579(00)00350-2

[14] Hooton T.M. Recurrent urinary tract infection in women // Int J Antimicrob Agents. 2001. Vol. 17, N 4. P. 259–268. doi: 10.1016/s0924-8579(00)00350-2

[15] Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259–268. doi: 10.1016/s0924-8579(00)00350-2

[16] Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014;312(16):1677–1684. doi: 10.1001/jama.2014.12842

[17] Grigoryan L., Trautner B.W., Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review // JAMA. 2014. Vol. 312, N 16. P. 1677–1684. doi: 10.1001/jama.2014.12842

[18] Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014;312(16):1677–1684. doi: 10.1001/jama.2014.12842

[19] Naber KG, Tirán-Saucedo J, Wagenlehner FME, RECAP group. Psychosocial burden of recurrent uncomplicated urinary tract infections. GMS Infect Dis. 2022;10:Doc01. doi: 10.3205/id000078

[20] Naber K.G., Tirán-Saucedo J., Wagenlehner F.M.E., RECAP group. Psychosocial burden of recurrent uncomplicated urinary tract infections // GMS Infect Dis. 2022. Vol. 10. ID Doc01. doi: 10.3205/id000078

[21] Naber KG, Tirán-Saucedo J, Wagenlehner FME, RECAP group. Psychosocial burden of recurrent uncomplicated urinary tract infections. GMS Infect Dis. 2022;10:Doc01. doi: 10.3205/id000078

[22] Kuzmenko AV, Kuzmenko VV, Gyaurgiev TA. Current trends in the treatment of chronic recurrent bacterial cystitis. Urologiia. 2020;(6):52–57. EDN: IRCVGU doi: 10.18565/urology.2020.6.52-57

[23] Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Современные тенденции в лечении хронического рецидивирующего бактериального цистита // Урология. 2020. № 6. С. 52–57. EDN: IRCVGU doi: 10.18565/urology.2020.6.52-57

[24] Kuzmenko AV, Kuzmenko VV, Gyaurgiev TA. Current trends in the treatment of chronic recurrent bacterial cystitis. Urologiia. 2020;(6):52–57. EDN: IRCVGU doi: 10.18565/urology.2020.6.52-57

[25] Komyakov BK, Ochelenko VA, Shevnin MV, et al. Postcoital cystitis as a cause of sexual dysfunction in women. Experimental and Clinical Urology. 2023;16(2):134–139. EDN: NCUIWI doi: 10.29188/2222-8543-2023-16-2-134-139

[26] Комяков Б.К., Очеленко В.А., Шевнин М.В., и др. Посткоитальный цистит как причина сексуальной дисфункции у женщин // Экспериментальная и клиническая урология. 2023. Т. 16, № 2. С. 134–139. EDN: NCUIWI doi: 10.29188/2222-8543-2023-16-2-134-139

[27] Komyakov BK, Ochelenko VA, Shevnin MV, et al. Postcoital cystitis as a cause of sexual dysfunction in women. Experimental and Clinical Urology. 2023;16(2):134–139. EDN: NCUIWI doi: 10.29188/2222-8543-2023-16-2-134-139

[28] Sinyakova LA. Recurrent urinary tract infection is a cross-disciplinary problem. Medical Council. 2014;(9):100–102. EDN: SWKYMX doi: 10.21518/2079-701X-2014-9-100-102

[29] Синякова Л.А. Рецидивирующие инфекции нижних мочевых путей — междисциплинарная проблема // Медицинский Совет. 2014. № 9. С. 100–102. EDN: SWKYMX doi: 10.21518/2079-701X-2014-9-100-102

[30] Sinyakova LA. Recurrent urinary tract infection is a cross-disciplinary problem. Medical Council. 2014;(9):100–102. EDN: SWKYMX doi: 10.21518/2079-701X-2014-9-100-102

[31] Newlands AF, Kramer M, Roberts L, et al. Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ). Neurourol Urodyn. 2024;43(4):902–914. doi: 10.1002/nau.25426

[32] Newlands A.F., Kramer M., Roberts L., et al. Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ) // Neurourol Urodyn. 2024. Vol. 43, N 4. P. 902–914. doi: 10.1002/nau.25426

[33] Newlands AF, Kramer M, Roberts L, et al. Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ). Neurourol Urodyn. 2024;43(4):902–914. doi: 10.1002/nau.25426

[34] Kupriyanov YA, Zaitsev AV, Bernikov AN, et al. Effectiveness of Wobenzym in combined therapy of chronic bacterial prostatitis. Results of systematic review and meta-analysis. Urology reports (St. Petersburg). 2024;14(1):51–64. EDN: UCDATS doi: 10.17816/uroved626639

[35] Куприянов Ю.А., Зайцев А.В., Берников А.Н., и др. Эффективность препарата Вобэнзим в комбинированной терапии хронического бактериального простатита. Результаты систематического обзора и метаанализа // Урологические ведомости. 2024. Т. 14, № 1. С. 51–64. EDN: UCDATS doi: 10.17816/uroved626639

[36] Kupriyanov YA, Zaitsev AV, Bernikov AN, et al. Effectiveness of Wobenzym in combined therapy of chronic bacterial prostatitis. Results of systematic review and meta-analysis. Urology reports (St. Petersburg). 2024;14(1):51–64. EDN: UCDATS doi: 10.17816/uroved626639

[37] Derevyanko TI, Papikova KA, Ryzhkova EV, et al. Role of enzymotherapy in treatment of chronic infectious processes of the lower urinary and urogenital region in women. Bulletin of Young Scientist. 2020;9(2):65–68. EDN: NFSBYK

[38] Деревянко Т.И., Папикова К.А., Рыжкова Э.В., и др. Роль энзимотерапии в лечении хронических инфекционных процессов нижних мочевых путей и урогенитальной области у женщин // Вестник молодого ученого. 2020. Т. 9, № 2. C. 65–68. EDN: NFSBYK

[39] Derevyanko TI, Papikova KA, Ryzhkova EV, et al. Role of enzymotherapy in treatment of chronic infectious processes of the lower urinary and urogenital region in women. Bulletin of Young Scientist. 2020;9(2):65–68. EDN: NFSBYK

[40] Kukhta OP, Aleksandruk OD, Neiko OV, et al. Clinical efficacy of treatment of women with chronic recurrent urogenital chlamydia infection. Pol Merkur Lekarski. 2023;51(3):239–244. doi: 10.36740/Merkur202303109

[41] Kukhta O.P., Aleksandruk O.D., Neiko O.V., et al. Clinical efficacy of treatment of women with chronic recurrent urogenital chlamydia infection // Pol Merkur Lekarski. 2023. Vol. 51, N 3. P. 239–244. doi: 10.36740/Merkur202303109

[42] Kukhta OP, Aleksandruk OD, Neiko OV, et al. Clinical efficacy of treatment of women with chronic recurrent urogenital chlamydia infection. Pol Merkur Lekarski. 2023;51(3):239–244. doi: 10.36740/Merkur202303109

[43] Makarov EV, Davidyan LU, Bogdasarov AU, Nesterov AS. Evaluation of therapy effectiveness and substantiation of treatment tactic of women with lesions of the neck of uterus caused by chlamydia trachomatis. Kazan medical journal. 2007;88(4):325–327. EDN: KVJJMD

[44] Макаров Э.В., Давидян Л.Ю., Богдасаров А.Ю., Нестеров А.С. Оценка эффективности терапии и обоснование тактики лечения женщин с хламидийными поражениями шейки матки // Казанский медицинский журнал. 2007. Т. 88, № 4. С. 325–327. EDN: KVJJMD

[45] Makarov EV, Davidyan LU, Bogdasarov AU, Nesterov AS. Evaluation of therapy effectiveness and substantiation of treatment tactic of women with lesions of the neck of uterus caused by chlamydia trachomatis. Kazan medical journal. 2007;88(4):325–327. EDN: KVJJMD

[46] Sundukov AV, Sternin YuI, Evdokimov EYu, et al. Systemic enzyme therapy of viral infections. Infectious diseases. 2010;8(1):92–97. EDN: MVGPRN

[47] Сундуков А.В., Стернин Ю.И., Евдокимов Е.Ю., и др. Системная энзимотерапия вирусных инфекций // Инфекционные болезни. 2010. Т. 8, № 1. С. 92–97. EDN: MVGPRN

[48] Sundukov AV, Sternin YuI, Evdokimov EYu, et al. Systemic enzyme therapy of viral infections. Infectious diseases. 2010;8(1):92–97. EDN: MVGPRN

[49] Kokhno NI, Gorshkova OV, Molodtsova LYu. Efficiency of systemic enzyme therapy in the combination treatment of pelvic inflammatory diseases in women. Obstetrics and Gynecology. 2022;(12):159–164. EDN: IIBUJW doi: 10.18565/aig.2022.294

[50] Кохно Н.И., Горшкова О.В., Молодцова Л.Ю. Эффективность системной энзимотерапии в комплексном лечении воспалительных заболеваний органов малого таза у женщин // Акушерство и гинекология. 2022. № 12. С. 159–164. EDN: IIBUJW doi: 10.18565/aig.2022.294

[51] Kokhno NI, Gorshkova OV, Molodtsova LYu. Efficiency of systemic enzyme therapy in the combination treatment of pelvic inflammatory diseases in women. Obstetrics and Gynecology. 2022;(12):159–164. EDN: IIBUJW doi: 10.18565/aig.2022.294

[52] Pushkar’ DIu, Gvozdev MIu, Tupikina NV. Questionnaires as a tool for assessing the quality of life in urogynecological patients. Russian bulletin of obstetrician-gynecologist. 2013;13(1):23–29. EDN: PXVRFN

[53] Пушкарь Д.Ю., Гвоздев М.Ю., Тупикина Н.В. Вопросники как инструмент оценки качества жизни пациентки урогинекологического профиля // Российский вестник акушера-гинеколога. 2013. Т. 13, № 1. С. 23–29. EDN: PXVRFN

[54] Pushkar’ DIu, Gvozdev MIu, Tupikina NV. Questionnaires as a tool for assessing the quality of life in urogynecological patients. Russian bulletin of obstetrician-gynecologist. 2013;13(1):23–29. EDN: PXVRFN

[55] Kazimirova OV, Yugay MN, Zhaparkul BD, et al. Application of scales and questionnaires in clinical medicine. Medicine and ecology. 2023;(4):5–24. EDN: CEQJLM doi: 10.59598/ME-2305-6045-2023-109-4-5-24

[56] Казимирова О.В., Югай М.Н., Жапаркул Б.Д., и др. Применение шкал и опросников в клинической медицине // Медицина и экология. 2023. № 4. С. 5–24. EDN: CEQJLM doi: 10.59598/ME-2305-6045-2023-109-4-5-24

[57] Kazimirova OV, Yugay MN, Zhaparkul BD, et al. Application of scales and questionnaires in clinical medicine. Medicine and ecology. 2023;(4):5–24. EDN: CEQJLM doi: 10.59598/ME-2305-6045-2023-109-4-5-24

[58] Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60(4):573–578. doi: 10.1016/s0090-4295(02)01829-0

[59] Parsons C.L., Dell J., Stanford E.J., et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity // Urology. 2002. Vol. 60, N 4. P. 573–578. doi: 10.1016/s0090-4295(02)01829-0

[60] Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60(4):573–578. doi: 10.1016/s0090-4295(02)01829-0

[61] Rafi B, Nassir A, Baazeem A, et al. Arabic translation and validation of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale. Bull Natl Res Cent. 2022;46:251. doi: 10.1186/s42269-022-00942-6

[62] Rafi B., Nassir A., Baazeem A., et al. Arabic translation and validation of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale // Bull Natl Res Cent. 2022. Vol. 46. ID 251. doi: 10.1186/s42269-022-00942-6

[63] Rafi B, Nassir A, Baazeem A, et al. Arabic translation and validation of Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale. Bull Natl Res Cent. 2022;46:251. doi: 10.1186/s42269-022-00942-6

[64] Al-Shukri SK, Kuzmin IV, Slesarevskaya MN, Ignashov YA. Use of the Russian version of pelvic pain and urgency/frequency patient symptom scale (PUF scale) in patients with the bladder pain syndrome. Urology reports (St. Petersburg). 2017;7(2):5–9. EDN: YUCBMP doi: 10.17816/uroved725-9

[65] Аль-Шукри С.Х., Кузьмин И.В., Слесаревская М.Н., Игнашов Ю.А. Применение русскоязычной версии шкалы симптомов тазовой боли, ургентности и частоты мочеиспускания (PUF Scale) у больных с синдромом болезненного мочевого пузыря // Урологические ведомости. 2017. Т. 7, № 2. C. 5–9. EDN: YUCBMP doi: 10.17816/uroved725-9

[66] Al-Shukri SK, Kuzmin IV, Slesarevskaya MN, Ignashov YA. Use of the Russian version of pelvic pain and urgency/frequency patient symptom scale (PUF scale) in patients with the bladder pain syndrome. Urology reports (St. Petersburg). 2017;7(2):5–9. EDN: YUCBMP doi: 10.17816/uroved725-9

Funding

MUCOS Pharma GmbHМУКОС Фарма ГмбХ

RIGHTS & PERMISSIONS

Eco-Vector